GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » YoY EPS Growth

Corix Bioscience (Corix Bioscience) YoY EPS Growth : 11.11% (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Corix Bioscience's YoY EPS Growth for the quarter that ended in Sep. 2017 was 11.11%.

Corix Bioscience's Earnings per Share (Diluted) for the three months ended in Sep. 2017 was $-0.16.


Corix Bioscience YoY EPS Growth Historical Data

The historical data trend for Corix Bioscience's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience YoY EPS Growth Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
YoY EPS Growth
Get a 7-Day Free Trial -5,799.99 97.66 53.49 99.99 34.59

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.88 100.00 80.00 54.17 11.11

Corix Bioscience YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Corix Bioscience's YoY EPS Growth for the fiscal year that ended in Dec. 2016 is calculated as:

YoY EPS Growth (A: Dec. 2016 )
=(Earnings per Share (Diluted) (A: Dec. 2016 )-Earnings per Share (Diluted) (A: Jan. 2015 ))/ | Earnings per Share (Diluted) (A: Jan. 2015 ) |
=(-0.52--0.795)/ | -0.795 |
=34.59 %

Corix Bioscience's YoY EPS Growth for the quarter that ended in Sep. 2017 is calculated as:

YoY EPS Growth (Q: Sep. 2017 )
=(Earnings per Share (Diluted) (Q: Sep. 2017 )-Earnings per Share (Diluted) (Q: Sep. 2016 )) / | Earnings per Share (Diluted) (Q: Sep. 2016 )) |
=(-0.16--0.18)/ | -0.18 |
=11.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corix Bioscience YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines